Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer

Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer

Conditions: Pancreatic Cancer; Stereotactic Body Radiation Therapy
Interventions: Drug: GC4419; Drug: Placebo; Radiation: Stereotactic Radiation Therapy (SBRT) 50 Gy; Radiation: Stereotactic Radiation Therapy (SBRT) 55 Gy
Sponsors: Galera Therapeutics, Inc.; M.D. Anderson Cancer Center
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 16, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments